APOFAS
Desconocido
DISCOVER: Death receptor signalling in tumour immune editing
APOFAS BIOTECH
participó en un
H2020:
H2020-MSCA-RISE-2017
During tumour development there is a bi-directional communication between cancer cells and immune cells; the process termed tumour immune ed...
2017-10-25 - 2022-12-31 | Financiado
2017-10-25 - 2022-12-31 | Financiado
* No se disponen de datos de la empresa actual.